EVIDENCE LIBRARY

What a Blue Scott Cocaine Test Really Shows

A blue Scott-test response is presumptive. Published cobalt-thiocyanate research explains lidocaine interference, reaction chemistry, and why confirmation records matter.

A blue response in a Scott or related cobalt-thiocyanate test is screening information. It is not, by color alone, a unique identification of cocaine. The distinction matters because the visible result arises from coordination chemistry that can involve organic bases other than cocaine.

A 2024 Journal of Forensic Sciences study by Raychelle Burks, Lars Öhrström, and Francoise M. Amombo Noa examined the chemistry behind these colored products. The work helps explain why a field observation must remain connected to the exact reagent sequence, sample, controls, and confirmatory laboratory analysis.

Why the test turns blue

Cobalt(II) thiocyanate reagents begin with cobalt species whose color and structure depend on their chemical environment. When certain protonated organic bases react with thiocyanate-containing cobalt species, the products can include blue ion pairs. That chemistry explains why a blue response can be useful while still lacking compound-level uniqueness.

The Burks study used ultraviolet-visible spectroscopy, attenuated-total-reflectance infrared spectroscopy, Raman spectroscopy, elemental analysis, and single-crystal X-ray diffraction to examine products formed with cocaine hydrochloride, lidocaine, and lidocaine hydrochloride monohydrate. The authors reported that the hallmark blue materials were consistent with related cobalt-thiocyanate ion-pair structures.

One analytical boundary is important. The blue material produced with cocaine hydrochloride was glassy and amorphous and could not be characterized by single-crystal X-ray diffraction. The structural conclusion for that material was supported through comparison using the other analytical techniques. A case reviewer should preserve that distinction rather than converting a supported chemical interpretation into a claim of direct crystal-structure measurement.

Why lidocaine matters

Lidocaine is relevant because it can occur as an adulterant in cocaine products and is a documented source of cobalt-thiocyanate color-test interference. In the Burks experiments, lidocaine hydrochloride monohydrate produced blue crystals whose structure was determined by single-crystal X-ray diffraction. The study also identified separate pink coordination products under other conditions.

The practical point is not that every blue test is caused by lidocaine. It is that blue is not a molecular fingerprint for cocaine. The observed result depends on which compounds are present and how they interact with the reagent. The broader issue is analytical selectivity: what a method can distinguish under the conditions actually used.

Procedure and proportions affect interpretation

The paper describes both a classic cobalt-thiocyanate reagent and the multi-step Scott procedure. Reagent composition, acidity, solvent, sample form, concentration, reagent-to-sample ratio, mixing, and observation sequence can affect which species form and where color appears.

Accordingly, a report that says only “tested positive for cocaine” omits information needed to evaluate the underlying observation. The record should identify the exact procedure, reagent preparation and lot, sample quantity, sequence, timing, phase or layer in which color appeared, controls, photographs, and every positive, negative, repeated, or inconclusive result.

Screening and identification answer different questions

The field test asks whether the sample produced a response consistent with the screening chemistry. Confirmatory analysis asks whether validated instrumental data support the identity of cocaine in the laboratory sample. Those are related but different propositions.

Review should therefore trace the material from the field-tested portion to the laboratory exhibit. It should identify the laboratory sampling plan, analytical methods, reference materials, quality controls, acceptance criteria, chromatograms or spectra, and the basis for the final identification. A later confirmation can establish cocaine in the tested laboratory portion, but it does not retroactively make the earlier blue color uniquely cocaine-specific.

Records that support a defensible review

  • The field-test manufacturer and exact product or reagent formulation.
  • Reagent lot, preparation date, expiration, storage history, blank, and positive and negative controls.
  • The written procedure and the operator’s training.
  • Sample description, quantity, physical form, packaging, heterogeneity, and sampling location.
  • Contemporaneous notes and photographs showing timing, sequence, and the layer or phase in which each color appeared.
  • Every test result, including negative, inconclusive, repeated, or overridden observations.
  • Chain-of-custody records connecting the field sample with the material submitted to the laboratory.
  • The laboratory sampling plan, instrumental data, quality-control records, reference standards, identification criteria, and report.

Where mass spectrometry was used, the review should examine the actual data and identification rules, not merely the instrument name. See Mass Spectrometry in Forensic Toxicology.

Interpretation boundary

The Scott test can serve a legitimate presumptive role. Its value does not require describing the blue response as conclusive. The scientifically supportable statement is narrower: the sample produced a response under a stated cobalt-thiocyanate procedure, and a separate validated analytical process is required to establish compound identity.

Sources

  1. Burks R, Öhrström L, Amombo Noa FM. Clarifying the complex chemistry of cobalt(II) thiocyanate-based tests for cocaine using single-crystal X-ray diffraction and spectroscopic techniques. Journal of Forensic Sciences. 2024;69(1):291-300. DOI.
  2. Philp M, Fu S. A review of chemical spot tests: a presumptive illicit drug identification technique. Drug Testing and Analysis. 2018;10:95-108. DOI.
  3. Scientific Working Group for the Analysis of Seized Drugs. SWGDRUG Recommendations, Version 8.2. Official recommendations.

* Read the full Content Disclaimer.